Cancer and Cancer Screening

Crossref Metadata :  
ISSN Online :  
Journal DOI :  
Current Issue :  Volume 1 - Issue 1 - 2019

Cancer and Cancer Screening : Open Access

About the Journal

Journal of Cancer and Cancer Screening is an online peer-reviewed journal that publishes significant and up-to-date original research papers, also includes Reviews as well as Editorials and Guest editorials on current topics within the fields of experimental and clinical oncology, from bench to bedside.

 

Journal of Cancer and Cancer Screening seeks manuscripts that include significant advances in cancer research and that offer a translational association from the laboratory to the treatment center to unlock new prospects for awareness, prevention, diagnosis and treatment of cancer.

 

Specific areas of interest include, but are not limited to: carcinogenesis - etiology, mechanisms; molecular biology; recent developments in tumor therapy; and epidemiology, mechanisms of progression of the malignant phenotype and metastatic disease; general diagnosis; laboratory diagnosis; diagnostic and experimental pathology; oncologic surgery; molecular alterations or biomarkers that predict response or resistance to treatment; translational research in targeted therapies; personalized medicine; novel applications of bioinformatics and biostatistics; tumor immunotherapy; large-scale molecular characterization of human tumors and innovative methods with potential applicability to clinical research.

 

Journal of Cancer and Cancer Screening allows the immediate publication of accepted articles and the presentation of outsized amount of data and additional information to make sure that research is distributed as resourcefully and promptly as possible to the scientific community.

 

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Open Access Publication and Creative Commons Licensing:

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share A like 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Ahead of Print policy:

Articles published online under the Ahead of Print models are considered published and can be cited and quoted using the DOI as the reference source. Acquaint has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.

The Following Fields Are Covered:

Acute & Chronic Leukemia's

Acute granulocytic leukemia

Advanced metastatic breast cancer

Anti-Cancer Drug Discovery

Autologous stem cell transplant

Burkitt's lymphoma

Cancer Epidemiology

Cancer Etiology

Cancer Genetics

Cancer Prevention methods

Cancer Statistics

Cancer Therapeutics

Cancer therapeutics and targets

Cancer Toxicology

Cancer vaccine

Carcinogenesis

Cellular and Molecular Biology of Cancer

Cellular Division and Proliferation

Cellular Signal Pathways

Chemotherapy

Chronic myelogenous leukemia

Clinical Oncology

Colon Cancer

Colorectal Cancer

Cytogenetics

DNA Repair and Apoptosis

Early Detection and Diagnosis

Electrofulguration

Genetic Toxicology

Genitourinary Cancer

Gynecologic Cancer

Hairy cell leukemia symptoms

Head and Neck Cancer

Hereditary prostate cancer genes

In situ non-invasive cancer

Intestinal cancer symptoms

Invasive lobular carcinoma

Large-scale molecular characterization of human tumors

Leukemia

Medical Oncology

Metastatic ovarian cancer

Microenvironment and immunology

Molecular alterations or biomarkers that predict response

Molecular and cellular pathobiology

Molecular biology

Molecular targeted agents and immune therapies

Oat cell cancer symptoms

Oncogenes

Oncogenomics, proteomics and metabolomics

Oncology diagnostic tools

Osteosarcoma

Ovarian Cancer

Philadelphia chromosome-positive chronic myelogenous leukemia

Pituitary gland cancer

Prevention and cancer epidemiology

Progression of the malignant phenotype

Radiation oncology

Radiology

Radiotherapy and biotherapy

Single and combined drug administration modalities

Skin Cancer

Squamous cell carcinoma

Stem Cell Biology

Surgical oncology

Therapeutics of the drugs

Tumor and stem cell biology

Tumor immunology and virology

Tumor Progression

Tumour therapy

Urologic Cancer

Waldenstrom macroglobulinemia

Wilms' Tumour

Wiskott-Aldrich syndrome